Back

Mortality predictors and prognostic implications of intermittent levosimendan therapy in advanced heart failure

11 May 2026 (13:00 - 14:07)
Organised by: Logo
Congress Presentation Part of: ePosters in chronic heart failure - pharmacotherapy (3) Pharmacotherapy HFA Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Rodrigo Brandao

Hospital Professor Doutor Fernando Fonseca, Amadora (Portugal)

7 More presentations in this session

Presentation thumbnail
Exploring medication adherence in heart failure from a patient perspective - a qualitative study
Mrs I. Gunnthorsdottir (Reykjavik, IS)
Abstract Slides
Presentation thumbnail
Impact of optimized guideline-directed medical therapy on mortality in octogenarians with heart failure and reduced ejection fraction: a real-world cohort study
Doctor E. Amao Ruiz (Reus, ES)
Abstract Slides
Presentation thumbnail
An interim report from a year in the life of a heart failure patient project: medication adjustment patterns at 3 and 6 months
Ms E. Brennan (Dublin, IE)
Abstract Slides
Presentation thumbnail
Cardiac cachexia as a key determinant of clinical stability in advanced heart failure patients treated with intermittent levosimendan
Doctor R. Brandao (Amadora, PT)
Abstract Slides
Presentation thumbnail
Sustained clinical stability and quality of life with intermittent levosimendan: a real-world experience of over 550 administrations
Doctor R. Brandao (Amadora, PT)
Abstract Slides

Access the full session

Session thumbnail
ePosters in chronic heart failure - pharmacotherapy (3)

The Event

Event poster

Heart Failure 2026

11 May 2026 13:00 CET
You may be interested in
thumbnail
Congress Session
Guideline-directed medical therapy implementation in special clinical scenarios
thumbnail
Congress Session
Meet the Experts: summation of the science - treatment of chronic heart failure in 2023
thumbnail
Congress Session
Acute heart failure therapies: from clinical trials to clinical practice

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources